Dorenkamp, M.; Nasiry, M.; Semo, D.; Koch, S.; Löffler, I.; Wolf, G.; Reinecke, H.; Godfrey, R.
Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function. Cells 2023, 12, 513.
https://doi.org/10.3390/cells12030513
AMA Style
Dorenkamp M, Nasiry M, Semo D, Koch S, Löffler I, Wolf G, Reinecke H, Godfrey R.
Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function. Cells. 2023; 12(3):513.
https://doi.org/10.3390/cells12030513
Chicago/Turabian Style
Dorenkamp, Marc, Madina Nasiry, Dilvin Semo, Sybille Koch, Ivonne Löffler, Gunter Wolf, Holger Reinecke, and Rinesh Godfrey.
2023. "Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function" Cells 12, no. 3: 513.
https://doi.org/10.3390/cells12030513
APA Style
Dorenkamp, M., Nasiry, M., Semo, D., Koch, S., Löffler, I., Wolf, G., Reinecke, H., & Godfrey, R.
(2023). Pharmacological Targeting of the RAGE-NFκB Signalling Axis Impedes Monocyte Activation under Diabetic Conditions through the Repression of SHP-2 Tyrosine Phosphatase Function. Cells, 12(3), 513.
https://doi.org/10.3390/cells12030513